durvalumab,tremelimumab
pfizer,astrazeneca
['tremelimumab', 'durvalumab', 'rectal', 'colorectal']
dr. jonathan loree #asco2022 with poster presentation of #cctg co.26 - impact of consensus molecular subtyping on survival in the co.26 trial of durvalumab plus tremelimumab versus best supportive care in metastatic colorectal cancer abstract link: 
The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.